Nuclear extracts were prepared from pooled prostate cancer vs. non-tumor adjacent tissues, then incubated with whole IgG control or PAF1 antibody, which resulted in moderate PAF1 depletion (Fig. 5c and Supplementary Fig. 7a). Here, PAF1 is linked to prostate cancer.